Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

This study has been terminated.
(Slow accrual in North America)
Sponsor:
Information provided by (Responsible Party):
Viventia Bio
ClinicalTrials.gov Identifier:
NCT00272181
First received: January 3, 2006
Last updated: December 22, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2007
  Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)